MDxHealth SA Receivables 2018-2024 | MDXH
MDxHealth SA receivables from 2018 to 2024. Receivables can be defined as the total amount of collectibles for a company
| MDxHealth SA Annual Receivables (Millions of US $) |
|
|---|---|
| 2024 | $14 |
| 2023 | $11 |
| 2022 | $9 |
| 2021 | $5 |
| 2020 | $4 |
| 2019 | $7 |
| 2018 | $19 |
| 2017 | $20 |
| 2016 | $0 |
| MDxHealth SA Quarterly Receivables (Millions of US $) |
|
|---|---|
| 2024-09-30 | $15 |
| 2024-06-30 | $13 |
| 2023-12-31 | $11 |
| 2023-09-30 | $9 |
| 2023-06-30 | |
| 2023-03-31 | $9 |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | $5 |
| 2022-03-31 | |
| 2021-12-31 | $5 |
| 2021-06-30 | $4 |
| 2020-12-31 | $4 |
| 2020-06-30 | $5 |
| 2019-12-31 | $7 |
| 2019-06-30 | $18 |
| 2018-12-31 | $19 |
| 2017-12-31 | $20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.081B | $0.090B |
| MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. | |||